+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Estrogen Increases Striatal GDNF Immunoreactivity with no Effect on Striatal FGF-2 Immunoreactivity of MPTP-Treated Mice

Estrogen Increases Striatal GDNF Immunoreactivity with no Effect on Striatal FGF-2 Immunoreactivity of MPTP-Treated Mice

Journal of the Medical Association of Thailand 98(Suppl. 9): S16

Glial derived neurotrophic factor (GDNF) and basic fibroblast growth factor (FGF-2) protect nigrostriatal dopaminergic (DA) neurons and their projections in animal models of Parkinson's disease (PD). Recent data indicate neuroprotective effects of estrogen in PD animal models through its anti-inflammatory and anti-oxidative effects, yet the hormonal effects on GDNF and FGF-2 expression in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice remain uninvestigated. To determine the effects of 17 beta-estradiol (E2) on DA innervation and the expression ofGDNFandFGF-2 in the striatum of MPTP-treated mice. Adult male mice were treated with E2 or vehicle for 11 days during which they were injected with MPTP or saline on the sixth day. The striatum was collected on day 11 and processedfor tyrosine hydroxylase (TH), GDNF and FGF-2 immunohistochemistry. Extent ofDA innervation and the expression of GDNF and FGF-2 in the striatum were assessed by measuring optical density of TH, GDNF and FGF-2 immunoreactivity, respectively. MPTP induced loss of DA axons and upregulation of FGF-2 expression, but did not alter GDNF level. E2 alleviated loss of DA axons, increased GDNF level, yet caused no change in FGF-2 level ofthe MPTP-intoxicated animals. One possible mechanism by which E2 protects nigrostriatal DA axons against MPTP is through upregulation ofstriatal GDNF.

Please choose payment method:

(PDF emailed within 1 workday: $29.90)

Accession: 057800052

Download citation: RISBibTeXText

PMID: 26817205

Related references

Increased striatal neuropeptide Y immunoreactivity and its modulation by deprenyl, clonidine and L-dopa in MPTP-treated mice. Journal of Neural Transmission 110(12): 1375-1391, 2003

The effect of estrogen upon L-DOPA evoked striatal dopamine release in vitro in MPTP-treated female mice. Society for Neuroscience Abstracts 18(1-2): 1578, 1992

Increased calbindin-D28K immunoreactivity in striatal spiny neurons in Huntingtons disease brains is also seen in rat striatal cells treated with quinolinic acid. Society for Neuroscience Abstracts 19(1-3): 1587, 1993

17Beta-estradiol reduces nitrotyrosine immunoreactivity and increases SOD1 and SOD2 immunoreactivity in nigral neurons in male mice following MPTP insult. Brain Research 1164: 24-31, 2007

Amantadine increases striatal dopamine turnover in MPTP-treated mice. Drug Development Research. 29(3): 222-226, 1993

LIGA 20 increases striatal dopamine levels in aged MPTP-treated mice refractory to GM1 ganglioside treatment. Neuroreport 5(2): 103-104, 1993

D2 antagonists induce striatal fos-like immunoreactivity in rats depleted of striatal dopamine as weanlings, but not as adults. Society for Neuroscience Abstracts 21(1-3): 1689, 1995

Localization of mGluR1a-like immunoreactivity and mGluR5-like immunoreactivity in identified populations of striatal neurons. Brain Research. 780(2): 210-217,. 12, 1998

Coexistence of alpha-2C adrenoceptor immunoreactivity with GABA, calbindin D28K and parvalbumin immunoreactivity in rat striatal neurons. Society for Neuroscience Abstracts 23(1-2): 1487, 1997

Mice lacking 5-HT1B receptors display a reduced effect of cocaine on striatal C-fos immunoreactivity. Society for Neuroscience Abstracts 21(1-3): 715, 1995

Quinolinic and kainic acids can enhance calcitonin gene-related peptide-like immunoreactivity in striatal neurons with substance P-like immunoreactivity. Brain Research 418(2): 392-397, 1987

Increases of substance P-like immunoreactivity within striatal-nigral structures after subacute methamphetamine treatment. Journal of Pharmacology and Experimental Therapeutics 229(2): 487-492, 1984

Indirubins deplete striatal monoamines in the Intact and MPTP-treated mouse brain and block kainate-induced striatal astrogliosis. Neurotoxicology and Teratology 32(2): 212-219, 2010